1 study found for:    RETAIN Trial—Drug: Alpha 1 Antitrypsin
Show Display Options
Rank Status Study
1 Active, not recruiting A Research Trial of Aralast in New Onset Diabetes (RETAIN) - Part I
Condition: Diabetes Mellitus, Type 1
Intervention: Drug: Alpha 1-Antitrypsin (AAT, Aralast NP)

Indicates status has not been verified in more than two years